About: QMPSB

An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org:8891

QMPSB is an arylsulfonamide-based synthetic cannabinoid that has been sold as a designer drug. QMPSB was first discovered by Nathalie Lambeng and colleagues in 2007. It acts as a full agonist of the CB1 receptor and CB2 receptor with Ki values of 3 nM and 4 nM, respectively. Many related derivatives were subsequently produced, with the main focus of this work being to increase selectivity for the non-psychoactive CB2 receptor. This work led on from an earlier series of sulfamoyl benzamide derivatives for which a patent was filed in 2004.

Property Value
dbo:abstract
  • QMPSB is an arylsulfonamide-based synthetic cannabinoid that has been sold as a designer drug. QMPSB was first discovered by Nathalie Lambeng and colleagues in 2007. It acts as a full agonist of the CB1 receptor and CB2 receptor with Ki values of 3 nM and 4 nM, respectively. Many related derivatives were subsequently produced, with the main focus of this work being to increase selectivity for the non-psychoactive CB2 receptor. This work led on from an earlier series of sulfamoyl benzamide derivatives for which a patent was filed in 2004. The quinolin-8-yl ester motif of QMPSB led to the discovery of other designer cannabinoids such as PB-22 and BB-22. (en)
dbo:casNumber
  • 312606-87-4
dbo:chEMBL
  • 245876
dbo:fdaUniiCode
  • 55Q8B94HS5
dbo:pubchem
  • 3929482
dbo:thumbnail
dbo:wikiPageID
  • 49163042 (xsd:integer)
dbo:wikiPageLength
  • 5769 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1105994232 (xsd:integer)
dbo:wikiPageWikiLink
dbp:c
  • 22 (xsd:integer)
dbp:casNumber
  • 312606 (xsd:integer)
dbp:chembl
  • 245876 (xsd:integer)
dbp:chemspiderid
  • 3151524 (xsd:integer)
dbp:h
  • 22 (xsd:integer)
dbp:iupacName
  • 8 (xsd:integer)
dbp:legalCa
  • Schedule II (en)
dbp:legalDe
  • NpSG (en)
dbp:legalUk
  • PSA (en)
dbp:n
  • 2 (xsd:integer)
dbp:o
  • 4 (xsd:integer)
dbp:pubchem
  • 3929482 (xsd:integer)
dbp:s
  • 1 (xsd:integer)
dbp:smiles
  • Cc1cccCOc3cccc4cccnc34 (en)
dbp:stdinchi
  • 1 (xsd:integer)
dbp:stdinchikey
  • WORIMYADZQJWOU-UHFFFAOYSA-N (en)
dbp:unii
  • 55 (xsd:integer)
dbp:wikiPageUsesTemplate
dcterms:subject
gold:hypernym
rdf:type
rdfs:comment
  • QMPSB is an arylsulfonamide-based synthetic cannabinoid that has been sold as a designer drug. QMPSB was first discovered by Nathalie Lambeng and colleagues in 2007. It acts as a full agonist of the CB1 receptor and CB2 receptor with Ki values of 3 nM and 4 nM, respectively. Many related derivatives were subsequently produced, with the main focus of this work being to increase selectivity for the non-psychoactive CB2 receptor. This work led on from an earlier series of sulfamoyl benzamide derivatives for which a patent was filed in 2004. (en)
rdfs:label
  • QMPSB (en)
owl:sameAs
prov:wasDerivedFrom
foaf:depiction
foaf:isPrimaryTopicOf
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License